Remicade News and Research

RSS
Remicade (infliximab) is able to reverse the symptoms of rheumatoid arthritis

Remicade (infliximab) is able to reverse the symptoms of rheumatoid arthritis

Analysis shows Remicade reduces pain associated with Crohn's disease

Analysis shows Remicade reduces pain associated with Crohn's disease

Study underscores the relative safety of infliximab, when used properly

Study underscores the relative safety of infliximab, when used properly

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

European recommended approval of Remicade for treatment of psoriatic arthritis

European recommended approval of Remicade for treatment of psoriatic arthritis

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

FDA approves new drug Enbrel for psoriasis

FDA approves new drug Enbrel for psoriasis

500,000 patients have now been treated with REMICADE® worldwide

500,000 patients have now been treated with REMICADE® worldwide

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis